How T2 Biosystems Inc. is utilizing miniaturized magnetic resonance technology for Lyme Disease

Rapid Diagnostic Tests and Their Effect on Antimicrobial Stewardship

T2 Biosystems Readies Biothreat Panel for FDA Submission While Keeping Eye on Sepsis Market

Increasing HAIs due to COVID-19 Stress the Need for a New Approach to Sepsis Diagnostics

HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects
T2 Biosystems awarded 100K for Lyme panel from HHS, Steven & Alexandra Cohen Foundation

Real-World Reports About Rapid Diagnostic Testing

T2 Biosystems inks distribution agreement in Baltic region

FDA grants breakthrough device designation for T2 Biosystems’ T2Lyme Panel
